Diverse recruitment for clinical trials is a huge issue – but what can drug developers do to overcome this challenge? Join Optimum’s Richard Staines as he discuses this thorny issue with Ariceum Therapeutic’s CMO, Germo Gericke, Leucid Bio’s CSO, John Maher and Non-Executive Director & Thought Leader Annalisa Jenkins.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av Optimum Perspectives
Visa alla avsnitt av Optimum PerspectivesOptimum Perspectives med Optimum Strategic Communications finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
